3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Zollinger-Ellison Syndrome
1
Vomiting
1
Precancerous Conditions
1
Nausea
1
Esophageal Neoplasms
1
Breast Neoplasms
1
Barrett Esophagus
1
Interventions
Dexamethasone
13
Ondansetron
9
Granisetron
7
Palonosetron
5
Olanzapine
5
Aprepitant
5
casopitant
3
Radiotherapy
3
Prochlorperazine
2
Electroacupuncture
2
Analgesia
2
Acupressure
2
sinomenine
1
netupitant, palosentron drug combination
1
netupitant
1
lerisetron
1
fosaprepitant
1
dolasetron
1
dexamethasone acetate
1
Therapeutics
1
Thalidomide
1
Taxes
1
Surveys and Questionnaires
1
Sugars
1
Metoclopramide
1
Hygiene
1
Haloperidol
1
Gemcitabine
1
Gabapentin
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Nausea
×
Esomeprazole
×
Clear all
NCT00206440
2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3
Terminated
43 enrolled
5 charts